首页> 外国专利> pharmaceutical compositions comprising combined antiplatelet substances for use in the treatment and prevention of vascular events of ischemic origin

pharmaceutical compositions comprising combined antiplatelet substances for use in the treatment and prevention of vascular events of ischemic origin

机译:包含组合的抗血小板物质的药物组合物,用于治疗和预防缺血性血管事件

摘要

PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND ANTIAGREGANT PLATELETARY SUBSTANCES COMBINED FOR. USE IN THE TREATMENT AND PREVENTION OF VASCULAR EVENTS OF ISCHEMIC ORIGIN The present invention refers to the pharmaceutical industry in general and the pharmaceutical industry that produces drugs for the control and prevention of ischemic vascular events in particular. More specifically, it is a composition formed by the combination of antiplatelet substances. The composition is characterized by the fact that the combination or combination consists of a selected platelet aggregating substance known as clopidogrel and an antiplatelet substance with hypolipidemic activity known as polyconasol, which produce a product with a synergistic effect for the treatment and prevention of events ischemic vascular diseases.
机译:理解抗血小板药物组合的药物成分。在治疗和预防缺血性起源的血管事件中的用途本发明总体上涉及制药业,特别是生产用于控制和预防缺血性血管事件的药物的制药业。更具体地说,它是由抗血小板物质结合形成的组合物。该组合物的特征在于,该组合或组合由选定的血小板聚集物质氯吡格雷和具有降血脂活性的抗血小板物质称为聚衣康醇组成,其产生具有协同作用的产物,用于治疗和预防缺血性血管事件疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号